Literature DB >> 28335075

Breastmilk with a high omega-6 to omega-3 fatty acid ratio induced cellular events similar to insulin resistance and obesity in 3T3-L1 adipocytes.

H Vaidya1, S K Cheema1.   

Abstract

BACKGROUND: An imbalance of omega (n)-3 and n-6 polyunsaturated fatty acids (PUFA) during critical periods of development may have adverse effects on the health of the newborn in later life.
OBJECTIVES: We hypothesized that breastmilk with higher n-6 to n-3 PUFA ratio will have higher inflammatory cytokines and initiate cellular events similar to insulin resistance and obesity.
METHODS: Breastmilk was collected from healthy women who gave natural birth at full term. Breastmilk fatty acids were measured using gas chromatography; samples were pooled based on the n-6 to n-3 PUFA ratio (high, medium and low), and soluble cytokines were measured. Pooled samples were used to treat 3T3-L1 cells; mRNA expression of diacylglycerol acyltransferase2, stearoyl-CoA desaturase-1, leptin and RPLPO was measured.
RESULTS: Breastmilk with a higher ratio of n-6 to n-3 PUFA showed higher pro-inflammatory cytokines; there was a direct correlation between n-6 PUFA and pro-inflammatory cytokines. Breastmilk with a higher ratio of n-6 to n-3 PUFA increased the expression of genes involved in lipogenesis.
CONCLUSIONS: Pro-inflammatory cytokines in breastmilk are associated with higher levels of n-6 PUFA in breastmilk and has the capacity to alter adipose tissue metabolism to likely predispose the newborn to a higher risk of obesity in later life.
© 2017 World Obesity Federation.

Entities:  

Keywords:  Adipocytes; breastmilk; obesity; pro-inflammation

Mesh:

Substances:

Year:  2017        PMID: 28335075     DOI: 10.1111/ijpo.12215

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  7 in total

1.  Breast Milk from Non-Obese Women with a High Omega-6 to Omega-3 Fatty Acid Ratio, but Not from Women with Obesity, Increases Lipogenic Gene Expression in 3T3-L1 Preadipocytes, Suggesting Adipocyte Dysfunction.

Authors:  Peter Isesele; Samantha Enstad; Pham Huong; Raymond Thomas; Carol L Wagner; Sarbattama Sen; Sukhinder K Cheema
Journal:  Biomedicines       Date:  2022-05-13

2.  Maternal pre-pregnancy weight status modifies the influence of PUFAs and inflammatory biomarkers in breastmilk on infant growth.

Authors:  Henry Nuss; Abby Altazan; Jovanny Zabaleta; Melinda Sothern; Leanne Redman
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

3.  Maternal Pre-Pregnancy Obesity Attenuates Response to Omega-3 Fatty Acids Supplementation During Pregnancy.

Authors:  Carmen Monthé-Drèze; Annie Penfield-Cyr; Marcela C Smid; Sarbattama Sen
Journal:  Nutrients       Date:  2018-12-04       Impact factor: 5.717

4.  Effect of Omega-3 Supplementation in Pregnant Women with Obesity on Newborn Body Composition, Growth and Length of Gestation: A Randomized Controlled Pilot Study.

Authors:  Carmen Monthé-Drèze; Sarbattama Sen; Sylvie Hauguel-de Mouzon; Patrick M Catalano
Journal:  Nutrients       Date:  2021-02-09       Impact factor: 5.717

5.  Polyunsaturated Fatty Acid Composition in Breast Milk Plasma of HIV-infected and Uninfected Mothers in Relation to Infant Clinical Outcomes.

Authors:  Lucy Mabaya; Hilda Tendisa Matarira; Donald Moshen Tanyanyiwa; Cuthbert Musarurwa; Johannes Mukwembi; Taona Emmah Mudluli; Tatenda Marera
Journal:  Nutr Metab Insights       Date:  2022-02-07

Review 6.  Adipose Tissue Development and Expansion from the Womb to Adolescence: An Overview.

Authors:  Camila E Orsso; Eloisa Colin-Ramirez; Catherine J Field; Karen L Madsen; Carla M Prado; Andrea M Haqq
Journal:  Nutrients       Date:  2020-09-08       Impact factor: 5.717

7.  The impact of maternal obesity and breast milk inflammation on developmental programming of infant growth.

Authors:  Samantha Enstad; Sukhinder Cheema; Raymond Thomas; Raina N Fichorova; Camilia R Martin; Perrie O'Tierney-Ginn; Carol L Wagner; Sarbattama Sen
Journal:  Eur J Clin Nutr       Date:  2020-08-19       Impact factor: 4.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.